The Centers for Medicare & Medicaid Services (CMS) is proposing new 2027 Medicare payment rates for laboratory services, aiming to save $1 billion annually by aligning payments closer to private-sector rates. This change will gradually reduce Medicare payments for clinical diagnostic laboratory tests, directly impacting large diagnostic laboratory providers.
CMS is proposing to reduce Medicare payments for laboratory services by an estimated $1 billion annually, bringing them closer to private-sector rates. This is a significant development for diagnostic laboratory providers, as Medicare has historically paid about 16% more than private payors. The reductions will be phased in gradually, with a maximum 15% reduction per year through 2029, but the long-term impact on revenue for companies heavily reliant on Medicare reimbursement, such as Quest Diagnostics, is negative. This creates a clear headwind for these companies, potentially impacting their profitability and growth prospects in the coming years.